Optas »

Takeda Pharmaceutical shares owned by Optas

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by Optas from 13F filings

Historical chart of Optas investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by Optas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by Optas

Quarter filed Position value Share count Share price at filing
2025-09-30 $165k 11k 14.64
2023-09-30 $157k 10k 15.47

More positions owned by Optas

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
NVIDIA Corporation (NVDA)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Apple (AAPL)
Spdr Series Trust Prtflo S&p500 Gw (SPYG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Amazon (AMZN)
Ishares Tr Core Us Aggbd Et (AGG)
Meta Platforms Cl A (META)

View all positions for Optas

Top funds holding Takeda Pharmaceutical

Capital Research Global Investors
Morgan Stanley
UBS Group
Goldman Sachs Group
FMR
Brandes Investment Partners
Renaissance Technologies
BlackRock
Toronto-Dominion Bank
Arrowstreet Capital, Limited Partnership
Millennium Management
First Trust Advisors
Northern Trust
Qube Research & Technologies
Citadel Advisors

View all funds holding Takeda Pharmaceutical